Brief: CEO Buys SEK 1.5 Mln Of Hansa Biopharma Shares
28/09/2026 12:48
BRIEF-CEO Buys SEK 1.5 Mln Of Hansa Biopharma Shares Sept 28 (Reuters) - Finansinspektionen:
HANSA BIOPHARMA CEO BUYS 47,000 SHARES IN COMPANY AT SEK 31.98 ON SEPTEMBER 25
Further company coverage: HNSA.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Hansa Biopharma AB
See all newsBrief: Hansa Biopharma Q3 Rev Up At SEK 143 Mln
Sweden's Hansa Biopharma Q3 revenue surges on SERB license deal
Brief: Hansa Biopharma Q3 Net Income SEK -178.5 Million
Brief: Hansa Biopharma Announces Positive Idefirix Paes Results Presented In The High-Impact Clinical Trials Session At Asn Kidney Week
Brief: Hansa Biopharma Submits IND Application To FDA For HNSA-5487 In GBS